Literature DB >> 1561361

Multiple myeloma and contrast media.

C S McCarthy1, J A Becker.   

Abstract

Contrast media administered intravenously are still thought by many to be a major cause of acute renal failure (ARF) in myeloma patients. Recently, several authors found that the predominant risk factors of ARF in myeloma patients are hypercalcemia, dehydration, infection, and Bence Jones proteinuria rather than contrast media. In a review of seven retrospective studies of myeloma patients receiving contrast media, 476 patients were noted to have undergone 568 contrast media studies, with an ARF prevalence of 0.6%-1.25%. One large series showed the incidence of ARF after administration of contrast media to be 0.15% in the general population. Although the administration of contrast media to myeloma patients is not totally risk free, it may be performed if the clinical need arises and the patient is well hydrated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1561361     DOI: 10.1148/radiology.183.2.1561361

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  18 in total

1.  Urine protein as a rapid screen for renal function in the ED: can it replace serum creatinine in selected patients?

Authors:  Jonathan Glauser; Aaron Montgomery
Journal:  Emerg Radiol       Date:  2004-05-05

Review 2.  Myeloma light chain cast nephropathy, a review.

Authors:  Insara Jaffer Sathick; Maria Eleni Drosou; Nelson Leung
Journal:  J Nephrol       Date:  2018-05-05       Impact factor: 3.902

3.  Acute renal failure from contrast medium: beware patients taking metformin...

Authors:  John A Sayer
Journal:  BMJ       Date:  2006-09-23

4.  Effect on renal function of an iso-osmolar contrast agent in patients with monoclonal gammopathies.

Authors:  Lorenzo Preda; Alberto Agazzi; Sara Raimondi; Carla Federica Lanfranchi; Rita Passerini; Albania Calvetta; Giovanni Martinelli; Massimo Bellomi
Journal:  Eur Radiol       Date:  2010-08-02       Impact factor: 5.315

Review 5.  Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

Authors:  Fulvio Stacul; Aart J van der Molen; Peter Reimer; Judith A W Webb; Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Peter Aspelin; Marie-France Bellin; Olivier Clement; Gertraud Heinz-Peer
Journal:  Eur Radiol       Date:  2011-08-25       Impact factor: 5.315

6.  Incidence of Contrast-Induced Nephropathy in Patients with Multiple Myeloma Undergoing Contrast-Enhanced Procedures.

Authors:  Maeve P Crowley; Vinitha N Prabhakaran; Oonagh M Gilligan
Journal:  Pathol Oncol Res       Date:  2017-09-13       Impact factor: 3.201

Review 7.  [Iodinated contrast agent-induced nephropathy].

Authors:  C Erley
Journal:  Radiologe       Date:  2007-09       Impact factor: 0.635

Review 8.  Contrast-induced nephropathy: pathogenesis and prevention.

Authors:  Robert E Cronin
Journal:  Pediatr Nephrol       Date:  2009-05-15       Impact factor: 3.714

Review 9.  Adverse effects of contrast media: incidence, prevention and management.

Authors:  H S Thomsen; W H Bush
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

10.  Cardiological Society of India practice guidelines for angiography in patients with renal dysfunction.

Authors:  S Bhandari; A Seth; K K Sethi; S Tyagi; R Gupta; S C Tiwari; S Mehrotra; Ashok Seth; Santanu Guha; P K Deb; Arup Dasbiswas; P P Mohanan; K Venugopal; Nakul Sinha; Brian Pinto; Amal Banerjee; G Sengottuvelu; Roxana Mehran; Peter Mc Collough
Journal:  Indian Heart J       Date:  2012-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.